Director/PDMR Shareholding

RNS Number : 6862A

Dechra Pharmaceuticals PLC

13 October 2009

 



Dechra Pharmaceuticals PLC 

("the Company")

 Directors / PDMR Share Dealing

13 October 2009

Dechra Pharmaceuticals PLC announces the following:

Exercise of LTIP options:

On 9 October 2009, the following Directors exercised options over ordinary shares of 1p each in the Company ("ordinary shares"), granted to them on 14 September 2006 pursuant to the Dechra Pharmaceuticals PLC Long Term Incentive Plan (the LTIP).  Each participant paid an exercise price of £1: 

Name	Capacity	Options Exercised	Shares Sold	Sale Price per share	Total beneficial shareholding following this announcement	Percentage of issued share capital
Ian Page	Director	47,412	19,537	£4.3586	707,731	1.08%
Simon Evans	Director	30,263	0	0	858,519	1.31%
Edwin Torr	Director	28,245	11,639	£4.3586	407,389	0.62%

The exercise of the LTIP options were subject to the achievement of performance conditions which were satisfied in full.

All Directors (other than Simon Evans) have sold sufficient shares (acquired pursuant to the LTIP exercise) in order to fund the resulting tax liability.  

Grant of SAYE options:

The following Directors/PDMR were yesterday granted options pursuant to the Dechra Pharmaceuticals Save As You Earn Scheme:

Director:

Edwin Torr        1,640 shares under option

PDMR:

Zoe Goulding        546 shares under option

The options have been granted over ordinary shares of 1pence each in the Company and have been granted with an exercise price of £3.32.

Enquiries:

Zoe Goulding

Company Secretary

01782 771100

 

END

 

 

RDSCKNKDDBDDOKD